Track Bronchogen in Peptimes™
Bronchogen is a synthetic peptide of four amino acids: Ala-Glu-Asp-Leu (AEDL). (Source: PubChem (NLM).)
Is Bronchogen FDA-approved?
No. Bronchogen isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Bronchogen
Also: AEDL, Ala-Glu-Asp-Leu
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousIntramuscularOralSublingualNasalTopicalOther
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In animals or the lab
In rats with a nitrogen dioxide model of chronic obstructive pulmonary disease, the authors reported that Bronchogen reversed changes in the bronchial lining and lung tissue and reduced signs of neutrophil inflammation. An animal study; it hasn't been tested in people.
Source: PMID 26468022, checked 1 Nov 2026
How to track it in Peptimes
Add Bronchogen in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: the app lets you record whichever route you used; none is established. Its routes are subcutaneous, intramuscular, oral, sublingual, nasal, topical and Other.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Bronchogen or any other compound.
More sources
- PubChem, Bronchogen, checked 1 Nov 2026: its structure, the tetrapeptide Ala-Glu-Asp-Leu.
- FDA, Drugs@FDA, checked 1 Nov 2026 through FDA’s openFDA Drugs@FDA data: no application lists Bronchogen as an active ingredient.